Scientific Programme

 CLICK HERE TO VIEW OR DOWNLOAD THE ET/ECIO FINAL PROGRAMME (PDF print version)

Thursday, April 10

07:00 Opening of Onsite Registration

10:00-12:00

CIRSE Foundation ILCA joint session: Blending interventional radiology and molecular medicine in HCC

Epidemiology and diagnosis of hepatocellular carcinoma
Chairs: J. Bruix (Barcelona/ES), J. Lammer (Vienna/AT)

Risk factors and cost-effective screening
M. Beaugrand (Paris/FR)
Imaging techniques for diagnosis and staging
B. Choi (Seoul/KR)
Tumour biospy: entering molecular staging
T. Roskams (Leuven/BE)
Outcome prediction: how to refine
J. Bruix (Barcelona/ES)

Interventional radiology and molecular medicine
Chairs: J. Bruix (Barcelona/ES), B. Choi (Seoul/KR)

Assessment of gene expression by imaging
M. Kuo (SanDiego, CA/US)
Functional imaging to assess molecular therapy
V. Vilgrain (Clichy/FR)
Is RECIST still valuable in hepatcellular carcinoma
R. Lencioni (Pisa/IT)
Targeting molecular pathways in the adjuvant setting after locoregional treatment
J.M. Llovet (Barcelona/ES)

12:00-12:30
Industry Symposium: Bayer Healthcare
Nexavar: The New Treatment Paradigm in Hepatocellular Carcinoma
Chair: Riccardo Lencioni (Pisa/IT)

New hope for unmet needs in advanced and recurrent hepatocellular carcinoma (HCC)
J. Bruix (Barcelona/ES)
Nexavar as the standard of care in HCC: implications for earlier stages in HCC and future directions
J.M. Llovet (Barcelona/ES)

13:00-13:45
Industry Symposium: Terumo/Biocompatibles
Infarction endpoint in bland embolization and drug eluting beads: latest updates
Chair: A. Denys (Lausanne/CH)

UFE treatment: long-term follow up of bead block registry
T.J. Kröncke (Berlin/DE)
TACE with DC beads as a pretransplant treatment for HCC: results with anatomopathological data
P. Goffette (Brussels/BE)
International hepatic arterial embolization registry of malignant tumours
R. Martin (Lexington, KY/US)

13:45-14:30
Industry Symposium: Angiodynamics
Innovations in embolization and radio frequency ablation

Drug-eluting bead-enhanced RF ablation of liver cancer
R. Lencioni (Pisa/IT)
Latest Optimization Updates of Radio Frequency Ablation lectrodes
L. Appelbaum (Jerusalem/IL)

15:00-16:45
Clinical Focus Session: Early-Stage Hepatocellular Carcinoma
Chairs: M. Colombo (Milan/IT), J.-F. Geschwind (Baltimore, MD/US)

Clinical overview and BCLC staging
L. Bolondi (Bologna/IT)
Current approaches in surgical resection
G. Torzilli (Milan/IT)
Transplantation versus resection
V. Mazzaferro (Milan/IT)
Interventional treatment of patients awaiting transplantation
L. Crocetti (Pisa/IT)
Transplantation after interventional downstaging
F. Filipponi (Pisa/IT)
Percutaneous ablation: chemical versus thermal
P.R. Mueller (Boston, MA/US)
Prevention of recurrence after curative treatment
M. Colombo (Milan/IT) 


15:00-15:45
Workshop: Radioembolization of Liver Malignancies: Techniques
Chair: C.M. Ferro (Genoa/IT)
Speakers: J.I. Bilbao (Pamplona/ES), T. Helmberger (Munich/DE) 


16:00-16:45
Workshop: Intraarterial Liver Treatments: Technical Tips
Chair: A. Siani (Naples/IT)
Speakers: F. Orsi (Milan/IT), C. Vignali (Pisa/IT)


17:00-18:45
Clinical Focus Session: Intermediate-Advanced Hepatocellular Carcinoma
Chairs: J. Bruix (Barcelona/ES), G. Simonetti (Rome/IT)

Chemoembolization: protocols and outcomes
G. Cornalba (Milan/IT)
Bland embolization versus chemoembolization
G. Getrajdman (New York, NY/US)
Chemoembolization with drug-eluting beads: experimental studies
J. Geschwind (Baltimore, MD/US)
Chemoembolization with drug-eluting beads: clinical trials
J. Lammer (Vienna/AT)
Combined chemoembolization and ablation
R. Lencioni (Pisa/IT)
Radioembolization
R. Salem (Chicago, IL/US)
Targeted sytemic therapy
J.M. Llovet (Barcelona/ES)
Recommendations for future research
J. Bruix (Barcelona/ES)


18:45-19:30
Welcome
Chairs: A. Adam (London/UK), G. Cornalba (Milan/IT), R. Lencioni (Pisa/IT)

Welcome by the President of the CIRSE Foundation
J. Lammer (Vienna/AT)
Welcome by the President of the Italian Society of Radiology
R. Lagalla (Palermo/IT)
Welcome by the President of the Italian Interventional Radiology Section
G. Gandini (Turin/IT)

Honorary Lecture
The future of cancer imaging and intervention
H. Hricak (New York, NY/US)

Friday, April 11

08:30 - 10:15
Clinical Focus Session: Colorectal Hepatic Metastases
Chairs: P.F. Conte (Modena/IT), M. Montorsi (Milan/IT)

Clinical overview and systemic chemotherapy
A. Falcone (Pisa/IT)
Outcomes of surgical resection
M. Montorsi (Milan/IT)
Outcomes of percutaneous ablation
L. Solbiati (Busto Arsizio/IT)
Chemoembolization
M. Soulen (Philadelphia, PA/US)
Radioembolization
J. Bilbao (Pamplona/ES)
Percutaneously implanted ports for intraarterial chemotherapy
Y. Arai (Tokyo/JP)
Intraarterial treatment with drug-eluting beads
C. Aliberti (Portomaggio/IT)
Special Topic: Interventional treatment of endocrine metastases
T. De Baère (Villejuif/FR)


08:30 - 09:15
Workshop: Extrahepatic Ablation: Technical Tips
Chair: B. Lees (London/UK)
Speakers: J. Palussière (Bordeaux/FR), A. Veltri (Turin/IT)

09:30 - 10:15
Workshop: How I do it: Chemoembolization with Drug Eluting Beads
Chair: M. Grosso (Cuneo/IT)
Speakers: R. Golfieri (Bologna/IT), K. Malagari (Athens/GR)

10:45-11:45
Clinical Focus Session: Kidney Tumours
Chairs: P.R. Mueller (Boston, MA/US), R. Pozzi Mucelli (Verona/IT)

Clinical overview and surgical management
C. Bremer (Münster/DE)
Patient selection and indications for percutaneous ablation
T. Helmberger (Munich/DE)
Outcomes of RF ablation
D. Breen (Southampton/UK)
Cryoablation versus RF ablation
D. Gervais (Boston, MA/US)
Current role of embolization in kidney tumours
M. Lee (Dublin/IE)

10:45 - 11:45
Workshop: Liver Ablation: Technical Tips
Chair: L. Crocetti (Pisa/IT)

Speakers: R. Hoffman (Munich/DE), C. Sofocleous (New York, NY/US)

12:15 - 13:00
Industry Symposium: Bracco
Contrast enhanced ultrasound in diagnosis and percutaneous treatment procedure -the winning situation
Chairs: G. Cornalba (Milan/IT), R. Lencioni (Pisa/IT)

The role of contrast enhanced ultrasound in HCC patient for diagnosis and during percutaneous treatment
C. Nicolau (Barcelona/ES)
Contrast enhanced ultrasound and fusion imaging: the optimal combination to guide and monitor percutaneous treatment
L. Solbiati (Busto Arsizio/Varese/IT)
Diagnostic performance of CEU’s in the follow-up of cancer patient
S. Yarmenitis (Heraklion/GR)

13:00 - 13:45
Industry Symposium: Boston Scientific
Combined treatment in hepatocellular carcinoma: radiofrequency ablation prior or after TACE?

RFA prior TACE
P. Chevallier (Nice/FR)
RFA after TACE
A. Denys (Lausanne/CH)
Discussion


14:00-15:30
Clinical Focus Session: Lung Tumours
Chairs: L. Bonomo (Rome/IT), D. Dupuy (Providence, RI/US)

Clinical overview and surgical management
C. Fernando (Boston, MA/US)
Ablation outcomes: primary lung cancer
R. Lencioni (Pisa/IT)
Ablation outcomes: metastases
T. De Baère (Villejuif/FR)
Complications of lung ablation
L. Crocetti (Pisa/IT)
Combined ablation and radiation therapy
D. Dupuy (Providence, RI/US)
Intra-arterial chemoembolization
T. Vogl (Frankfurt/DE)
Special Topic: Bronchial artery embolization
M. Lee (Dublin/IE)


16:00-18:00
Technical Focus Session: What's New in Ablation Devices and Transarterial Agents
Chairs: J. Geschwind (Baltimore, MD/US), R. Lencioni (Pisa/IT)

Ethanol ablation
M.-D. Lu (Guangzhou/CN)
Chemical ablation and electrolysis
M. Soulen (Philadelphia, PA/US)
Radiofrequency ablation
R. Lencioni (Pisa/IT)
Microwave ablation
F. Lee (Madison, WI/US)
Cryoablation
M. Callstrom (Jacksonville, FL/US)
Focused Ultrasound
S. Solomon (New York, NY/US)
Electroporation
G. Onik (Celebration, FL/US)
Intra-arterial therapies using tumour metabolism inhibitors
J. Geschwind (Baltimore, MD/US)

18:15-19:00
Industry Symposium: Covidien
MWA, a new milestone within ablative therapies
Chair: L. Solbiati (Busto Arsizio/IT)

Basıc Physıcs and Bıophysıcs of Mıcrowave Ablatıon
J. Case (Boulder, CO/US)
Microwave vs. radiofrequency: lessons learned from experimental animal studies
L. Crocetti (Pisa/IT), R. Lencioni (Pisa/IT)
MWA: Overview of Current and Future Clinical Applications in Patients
D. Dupuy (Providence, RI/US)

Saturday, April 12

08:30-10:00
Technical Focus Session: Imaging Guidance, Monitoring and Follow-up
Chairs: C. Bartolozzi (Pisa/IT), R. Passariello (Rome/IT)

Contrast ultrasound and real-time fusion imaging
L. Solbiati (Busto Arsizio/IT)
Angio-CT
Y. Arai (Tokyo/JP)
MR imaging
P. Pereira (Tübingen/DE)
Robotics
S. Solomon (New York, NY/US)
Imaging assessment of tumor viability
C. Bartolozzi (Pisa/IT)
Tumour response criteria in Interventional Oncology
D. Cioni (Pisa/IT)

10:00-10:45
Industry Symposium: GE Healthcare 
Innovation and practical applications in breast and liver cancer. New interventional solutions and applied imaging technologies
Chair: D. Gianfelice (Laval/CA)

Changing demographics of cancer in Europe
D.Gianfelice (Laval/CA)
Innovative approaches improve breast cancer outcomes
D.Gianfelice (Laval/CA)
Abdominal cancer. New interventional solutions and applied imaging technologies.
T. de Baère (Villejuif/FR)


11:15-11:45
Industry Symposium: Philips
Contrast-Enhanced Ultrasound for Interventional Oncology

The role of 3D CEUS in assessing the efficacy of radiofrequency ablation of HCC and the role of quantitative techniques for the evaluation of the efficacy of antitumoral treatments
C. Serra (Bologna/IT)


11:45-12:45
Clinical Focus Session: Bone tumours
Chairs: B. Charboneau (Jacksonville, FL/US), M. Hicks (Houston, TX/US)

Cryoablation
S. Masala (Rome/IT)
Ablation: indications and patient selection
A. Kelekis (Athens/GR)
Treatment of osteoid osteoma
A. Gangi (Strasbourg/FR)
Ablation of bone metastases
B. Charboneau (Rochester, MN/US)
Intraarterial therapy of bone metastases
J. Chiras (Paris/FR)
Combined RF ablation and cementoplasty
G. Anselmetti (Turin/IT)

11:45-12:45
Workshop: Complications of Percutaneous Ablation
Chair: O. Akhan (Ankara/TR)

Speakers: M. Bezzi (Rome/IT), T. Jakobs (Munich/DE)

12:45-13:45
Clinical Focus Session: New Applications
Chairs: M. Brunner (Chicago, IL/US), G. Dorfman (Worcester, MA/US)

Head and neck
M. Mack (Frankfurt/DE)
Breast
V.S. Klimberg (Little Rock, AR/US), G. Manenti (Rome/IT)
Prostate
G. Onik (Celebration, FL/US)
Pelvis and retroperitoneum
A. Gillams (London/UK)
Focused ultrasound ablation of thyroid nodules
L. Leenhardt (Paris/FR)
Special topic: Future research in Interventional Oncology 
G. Dorfman (Worcester, MA/US)

                               

Back

print page

Top